Development of a DNA Vaccine Targeting Human Papillomavirus Type 16 Oncoprotein E6

Human papillomavirus (HPV), particularly type 16 (HPV-16), is present in more than 99% of cervical cancers. The HPV oncoproteins E6 and E7 are constantly expressed and therefore represent ideal targets for HPV vaccine development. We previously developed DNA vaccines encoding calreticulin (CRT) link...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Peng, Shiwen, Ji, Hongxiu, Trimble, Cornelia, He, Liangmei, Tsai, Ya-Chea, Yeatermeyer, Jessica, Boyd, David A. K., Hung, Chien-Fu, Wu, T.-C.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2004
Предметы:
Vaccines and Antiviral Agents
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC479075/
https://ncbi.nlm.nih.gov/pubmed/15280455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.78.16.8468-8476.2004
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы